Seven (7) day platelet concentrate - blood products & blood components

Active Indefinite Delivery Contract Awarded Last action

Contract number
W81K0023D0009
Awardee
Awarding agency
Task orders
4 $5,155,687 obligated

Award facts

Combined order value
$6,855,127 Current and potential, with all options
Last date to order 61% complete
IDV ceiling 61% used
$8,430,460.00
Award type
Single award
Who can order
Only the awarding agency
Funding agency
Defense Health Agency Department of Defense
NAICS code
621991 Blood and Organ Banks
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

About this IDV

This federal indefinite delivery contract (IDC) was awarded by the Defense Health Agency (DHA) to South Texas Blood & Tissue Center (STBTC), a non-profit subsidiary of Biobridge Global. The $8,430,460 single-award IDC has an ultimate completion date of September 30, 2028 and enables STBTC to provide ongoing delivery of critical blood products, including seven-day platelet concentrates, red blood cells, and single donor plasma, to support medical treatments for veterans and military personnel primarily at the Brooke Army Medical Center in Fort Sam Houston, Texas.

The IDC is part of STBTC's existing federal contract portfolio, which includes a $5,000,000 IDC with the Department of Veterans Affairs Veterans Health Administration extending through February 2027. Under the current DHA IDC, STBTC has received two delivery orders valued at $1,632,700 and $1,296,539 for the supply of blood products and components. The original pre-solicitation notice indicates the government's intent to procure ongoing monthly shipments of specialized blood products to military medical facilities, with a focus on vendor capacity, delivery performance, and product quality and safety standards.

Task orders

Transactions

Action Obligated Date
Additional Work (new agreement, FAR part 6 applies) P00002 · Modification to add 2 sub-clins for the red blood cells leukocyte reduced and the single donor plasma frozen. $0
Additional Work (new agreement, FAR part 6 applies) P00001 · Seven (7) day platelet concentrate - blood products and services contract - decrease, increase, DE-obligate quantities and add a new specialty clin. $0
Original award $0

Quick answers

Who was awarded contract W81K0023D0009?

W81K0023D0009 was awarded to South Texas Blood & Tissue Center by Medical Command (Department of the Army) on October 1, 2023.

How much is contract W81K0023D0009 worth?

Orders under W81K0023D0009 have obligated $5,155,687. Their combined current value, with exercised options, is $6,855,127. W81K0023D0009's own ceiling is $8,430,460.

How many orders have been placed under contract W81K0023D0009?

4 orders have been placed under W81K0023D0009, the latest on October 1, 2026.

Which agency awarded contract W81K0023D0009?

Medical Command (Department of the Army) awarded W81K0023D0009, with funding from Defense Health Agency (Department of Defense).

Who can order from contract W81K0023D0009?

W81K0023D0009 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.

Was contract W81K0023D0009 competed?

The extent of competition for W81K0023D0009 was not competed under sap. The government received 1 offer.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV